Shares of Fagron NV (OTCMKTS:ARSUF – Get Free Report) shot up 3.3% on Tuesday . The company traded as high as $27.90 and last traded at $27.90. Approximately 200 shares were traded during mid-day trading, a decline of 98% from the average session volume of 12,800 shares. The stock had previously closed at $27.00.
Fagron Stock Performance
The stock’s 50 day moving average is $26.43 and its 200-day moving average is $26.42.
About Fagron
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Further Reading
- Five stocks we like better than Fagron
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
